Environmental, pharmacological and genetic influences on the spread of drug-resistant malaria

Proceedings of the Royal Society B: Biological Sciences

Volumn 278, Issue 1712, 2011, Pages 1705-1712

  Antao, Tiago ^a   Hastings, Ian M ^a  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

Drug resistance; Epistasis; Malaria; Plasmodium falciparum; Prevalence; Selection

Indexed keywords

DISEASE PREVALENCE; DISEASE SPREAD; DISEASE TRANSMISSION; DRUG RESISTANCE; EPISTASIS; HETEROGENEITY; MALARIA;

PLASMODIUM FALCIPARUM;

EID: 79955432472     PISSN: 09628452     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rspb.2010.1907     Document Type: Article

References (45)

1. Snow, R. W., Guerra, C. A., Noor, A. M., Myint, H. Y. & Hay, S. I. 2005 The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434, 214-217. (doi:10.1038/nature03342)
2. Olliaro, P. 2005 Drug resistance hampers our capacity to roll back malaria. Clin. Infect. Dis. 41(Suppl. 4), S247-S257. (doi:10.1086/430785)
3. Rogers, W. O., Sem, R., Tero, T., Chim, P., Lim, P., Muth, S., Socheat, D., Ariey, F. & Wongsrichanalai, C. 2009 Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia. Malar. J. 8, 10. (doi:10.1186/1475-2875-8-10).
4. Dondorp, A. M. et al. 2009 Artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 361, 455-467. (doi:10.1056/NEJMoa0808859)
5. Anderson, T. J. et al. 2000 Microsatellite markers reveal a spectrum of population structures in the malaria parasite Plasmodium falciparum. Mol. Biol. Evol. 17, 1467-1482.
6. Mzilahowa, T., McCall, P. J. & Hastings, I. M. 2007 Sexual population structure and genetics of the malaria agent P. falciparum. PLoS ONE 2, pe613. (doi:10.1371/ journal.pone.0000613)
7. Hastings, I. M. 1997 A model for the origins and spread of drug-resistant malaria. Parasitology 115, 133-141. (doi:10.1017/S0031182097001261)
8. Hastings, I. M. & D'Alessandro, U. 2000 Modelling a predictable disaster: the rise and spread of drug-resistant malaria. Parasitol. Today 16, 340-347. (doi:10.1016/ S0169-4758(00)01707-5)
9. Wargo, A. R., Huijben, S., de Roode, J. C., Shepherd, J. & Read, A. F. 2007 Competitive release and facilitation of drug-resistant parasites after therapeutic chemotherapy in a rodent malaria model. Proc. Natl Acad. Sci. USA 104, 19 914-19 919. (doi:10.1073/pnas.0707766104)
10. Boni, M. F., Smith, D. L. & Laxminarayan, R. 2008 Benefits of using multiple first-line therapies against malaria. Proc. Natl Acad. Sci. USA 105, 14216-14221. (doi:10.1073/pnas.0804628105).
11. Yeung, S., Pongtavornpinyo, W., Hastings, I. M., Mills, A. J. & White, N. J. 2004 Antimalarial drug resistance, artemisinin-based combination therapy, and the contribution of modeling to elucidating policy choices. Am. J. Trop. Med. Hyg. 71, 179-186.
12. Anderson, T. J. C. & Roper, C. 2005 The origins and spread of antimalarial drug resistance: lessons for policy makers. Acta Trop. 94, 269-280. (doi:10.1016/j.actatropica.2005.04.010).
13. Looareesuwan, S., Viravan, C., Webster, H. K., Kyle, D. E., Hutchinson, D. B. & Canfield, C. J. 1996 Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. Am. J. Trop. Med. Hyg. 54, 62-66.
14. Plowe, C. et al. 1997 Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. J. Infect. Dis. 176, 1590-1596. (doi:10. 1086/514159)
15. Price, R. N. et al. 2004 Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet 364, 438-447. (doi:10.1016/S0140-6736(04)16767-6)
16. Sibley, C. et al. 2001 Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next? Trends Parasitol. 17, 582-588. (doi:10.1016/S1471-4922(01)02085-2)
17. Langhorne, J., Ndungu, F. M., Sponaas, A.-M. & Marsh, K. 2008 Immunity to malaria: more questions than answers. Nat. Immunol. 9, 725-732. (doi:10. 1038/ni.f.205).
18. Rogerson, S. J., Wijesinghe, R. S. & Meshnick, S. R. 2010 Host immunity as a determinant of treatment outcome in Plasmodium falciparum malaria. Lancet Infect. Dis. 10, 51-59. (doi:10.1016/S1473-3099(09)70322-6)
19. Guerin, P. J., Olliaro, P., Nosten, F., Druilhe, P., Laxminarayan, R., Blinka, F., Kilama, W. L., Ford, N. & White, N. J. 2002 Malaria: current status of control, diagnosis, treatment, and a proposed agenda for research and development. Lancet Infect. Dis. 2, 564-573. (doi:10. 1016/S1473-3099(02)00372-9)
20. Dye, C. & Williams, B. G. 1997 Multigenic drug resistance among inbred malaria parasites. Proc. R. Soc. Lond. B 264, 61-67. (doi:10.1098/rspb.1997.0009)
21. Osman, M. E., Mockenhaupt, F. P., Bienzle, U., Elbashir, M. I. & Giha, H. A. 2007 Field-based evidence for linkage of mutations associated with chloroquine (PfCRT/PfMDR1) and sulfadoxine-pyrimethamine (PfDHFR/PfDHPS) resistance and for the fitness cost of multiple mutations in P. falciparum. Infect. Genet. Evol. 7, 52-59. (doi:10.1016/j.meegid.2006.03.008)
22. Wellems, T. E. & Plowe, C. V. 2001 Chloroquineresistant malaria. J. Infect. Dis. 184, 770-776. (doi:10.1086/322858)
23. Roper, C., Pearce, R., Nair, S., Sharp, B., Nosten, F. & Anderson, T. 2004 Intercontinental spread of pyrimethamine- resistant malaria. Science 305, 1124. (doi:10.1126/science.1098876)
24. Vaidya, A. & Mather, M. 2000 Atovaquone resistance in malaria parasites. Drug Resist. Update 3, 283-287. (doi:10.1054/drup.2000.0157)
25. White, N. J. & Pongtavornpinyo, W. 2003 The de novo selection of drug-resistant malaria parasites. Proc. R. Soc. Lond. B 270, 545-554. (doi:10.1098/rspb.2002.2241).
26. Pongtavornpinyo, W., Hastings, I. M., Dondorp, A., White, L. J., Maude, R. J., Saralamba, S., Day, N. P., White, N. J. & Boni, M. F. 2009 Probability of emergence of antimalarial resistance in different stages of the parasite life cycle. Evol. Appl. 2, 52-61. (doi:10.1111/j. 1752-4571.2008.00067.x)
27. Olliaro, P. 2001 Mode of action and mechanisms of resistance for antimalarial drugs. Pharmacol. Ther. 89, 207-219. (doi:10.1016/S0163-7258(00)00115-7)
28. Hastings, I. M. 2006 Complex dynamics and stability of resistance to antimalarial drugs. Parasitology 132, 615-624. (doi:10.1017/S0031182005009790)
29. Ursing, J., Schmidt, B. A., Lebbad, M., Kofoed, P. E., Dias, F., Gil, J. P. & Rombo, L. 2007 Chloroquine resistant P. falciparum prevalence is low and unchanged between 1990 and 2005 in Guinea-Bissau: an effect of high chloroquine dosage? Infect. Genet. Evol. 7, 555-561. (doi:10.1016/j.meegid.2007.03.006)
30. Talisuna, A., Langi, P., Bakyaita, N., Egwang, T., Mutabingwa, T. K., Watkins, W., Van Marck, E. & D'Alessandro, U. 2002 Intensity of malaria transmission, antimalarial-drug use and resistance in Uganda: what is the relationship between these three factors? Trans. R. Soc. Trop. Med. Hyg. 96 310-317. (doi:10.1016/S0035-9203(02)90108-2)
31. Hastings, I. M., Watkins, W. M. & White, N. J. 2002 The evolution of drug resistant malaria; the role of drug elimination half-life. Phil. Trans. R. Soc. Lond. B 357, 505-519. (doi:10.1098/rstb.2001.1036)
32. Hastings, I. M. & Watkins, W. M. 2006 Tolerance is the key to understanding antimalarial drug resistance. Trends Parasitol. 22, 71-77. (doi:10.1016/j.pt.2005.12.011)
33. Koella, J. C. & Antia, R. 2003 Epidemiological models for the spread of anti-malarial resistance. Malar. J. 2, 3. (doi:10.1186/1475-2875-2-3)
34. Babiker, H. A., Hastings, I. M. & Swedberg, G. 2009 Impaired fitness of drug-resistant malaria parasites: evidence and implication on drug-deployment policies. Expert Rev. Anti Infect. Ther. 7, 581-593. (doi:10.1586/eri.09.29)
35. Walliker, D., Hunt, P. & Babiker, H. 2005 Fitness of drugresistant malaria parasites. Acta Trop. 94, 251-259. (doi:10.1016/j.actatropica.2005.04.005)
36. Laufer, M. K., Thesing, P. C., Eddington, N. D., Masongo, R., Dzinjalamala, F. K., Takala, S. L., Taylor, T. E. & Plowe, C. V. 2006 Return of chloroquine antimalarial efficacy in Malawi. N. Engl. J. Med. 355, 1959-1966. (doi:10.1056/NEJMoa062032)
37. Kublin, J. G. et al. 2003 Reemergence of chloroquinesensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. J. Infect. Dis. 187, 1870-1875. (doi:10.1086/375419)
38. Schwenke, A., Brandts, C., Philipps, J., Winkler, S., Wernsdorfer, W. H. & Kremsner, P. G. 2001 Declining chloroquine resistance of Plasmodium falciparum in Lambaréné, Gabon from 1992 to 1998. Wien. Klin. Wochenschr. 113, 63-64.
39. Cortese, J. F., Caraballo, A., Contreras, C. E. & Plowe, C. V. 2002 Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America. J. Infect. Dis. 186, 999-1006. (doi:10.1086/342946)
40. Yang, H., Yang, Y., Yang, P., Li, X., Gao, B., Zhang, Z., Yang, Z. & Cui, L. 2008 Monitoring Plasmodium falciparum chloroquine resistance in Yunnan province, China, 1981-2006. Acta Trop. 108, 44-49. (doi:10. 1016/j.actatropica.2008.08.010)
41. Plowe, C. V., Kublin, J. G., Dzinjalamala, F. K., Kamwendo, D. S., Chimpeni, P., Molyneux, M. E. & Taylor, T. E. 2004 Sustained clinical efficacy of sulfadoxine- pyrimethamine for uncomplicated falciparum malaria in Malawi after 10 years as first line treatment: five year prospective study. Brit. Med. J. 328, 545. (doi:10.1136/bmj.37977.653750.EE)
42. Pearce, R. J., Drakeley, C., Chandramohan, D., Mosha, F. & Roper, C. 2003 Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum in three districts of northern Tanzania. Antimicrob. Agents Chemother. 47, 1347-1354. (doi:10.1128/AAC.47.4.1347-1354.2003)
43. Babiker, H. A., Satti, G., Ferguson, H., Bayoumi, R. & Walliker, D. 2005 Drug resistant Plasmodium falciparum in an area of seasonal transmission. Acta Trop. 94, 260-268. (doi:10.1016/j.actatropica.2005.04.007)
44. Hastings, I. M. & Smith, T. A. 2008 MALHAPLOFREQ: a computer programme for estimating malaria haplotype frequencies from blood samples. Malar. J. 7, 130. (doi:10.1186/1475-2875-7-130)
45. Hastings, I. M., Nsanzabana, C. & Smith, T. A. 2010 A comparison of methods to detect and quantify the markers of antimalarial drug resistance. Am. J. Trop. Med. Hyg. 83, 489-495. (doi:10.4269/ajtmh.2010.10- 0072)